Kidney Diseases Completed Phase 2 / 3 Trials for Spironolactone (DB00421)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00106561Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyPrevention